Table of Contents 2
List of Tables 5
List of Figures 5
Acor Pharmaceuticals, Inc. Spshot 6
Acor Pharmaceuticals, Inc. Overview 6
Key Information 6
Key Facts 6
Acor Pharmaceuticals, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Acor Pharmaceuticals, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combition Treatment Modalities 13
Acor Pharmaceuticals, Inc. - Pipeline Products Glance 14
Acor Pharmaceuticals, Inc. - Late Stage Pipeline Products 14
Pre-Registration Products/Combition Treatment Modalities 14
Acor Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combition Treatment Modalities 15
Phase I Products/Combition Treatment Modalities 16
Acor Pharmaceuticals, Inc. - Early Stage Pipeline Products 17
Preclinical Products/Combition Treatment Modalities 17
Discovery Products/Combition Treatment Modalities 18
Acor Pharmaceuticals, Inc. - Drug Profiles 19
crisaborole 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
epetraborole 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AN-2718 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
AN-3485 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AN-4161 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
AN-4169 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
AN-5973 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule 1 for Tuberculosis 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule 2 for Tuberculosis 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule for Shigellosis 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecules for Chagas Disease 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules for Leishmaniasis 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecules for Nematodal Diseases 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecules for Skin Inflammation 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecules to Inhibit PDE4 for Psoriasis 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Acor Pharmaceuticals, Inc. - Pipeline Alysis 36
Acor Pharmaceuticals, Inc. - Pipeline Products by Target 36
Acor Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 37
Acor Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 38
Acor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 39
Acor Pharmaceuticals, Inc. - Recent Pipeline Updates 40
Acor Pharmaceuticals, Inc. - Dormant Projects 45
Acor Pharmaceuticals, Inc. - Discontinued Pipeline Products 46
Discontinued Pipeline Product Profiles 46
epetraborole 46
Acor Pharmaceuticals, Inc. - Locations And Subsidiaries 47
Head Office 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49